Top Stories

Amgen's 'Dmab' in need of differentiation: analyst

December 18, 2007

Trial results for an Amgen pipeline drug showed the biologic is comparable to existing therapies in its ability to boost bone density in women with cancer.
 

Saatchi Healthcare rebrands for more holistic approach

December 14, 2007

With a stable of big-spending clients and one of advertising's most storied names, you might think Saatchi & Saatchi Healthcare Communications Group would be the last shop in need of a rebrand.
 

FDA seeks more info on Cervarix

December 17, 2007

GlaxoSmithKline said approval of Cervarix will be delayed in the US after FDA regulators requested more information on the vaccine in a "complete response letter" to the drugmaker.
 

In Other News

Lilly CEO Taurel to retire

December 18, 2007

Eli Lilly announced that CEO Sidney Taurel will retire effective March 31, 2008, to be replaced by John Lechleiter, current COO, who will assume the chief exec role on April 1.
 

FDA rejects Merck's Mevacor OTC bid

December 18, 2007

An FDA advisory panel has rejected Merck's bid to sell the cholesterol-lowering drug Mevacor without a prescription.
 

Product news

December 18, 2007

Forest Laboratories and Mylan announced that the novel beta blocker Bystolic (nebivolol) was approved by the FDA for the treatment of hypertension.
 

People news

December 18, 2007

Novalar Pharmaceuticals, a dental specialty pharmaceutical company has appointed Robert Stefanovich CFO and Jeffrey Lord VP of sales.
 

Webcast

5 BIG REASONS for taking pharmaceutical marketing online

Available on demand
Many pharmaceutical marketers are still unsure about entering the digital landscape and even less certain of what to do when they get there. Interactive marketing experts from Google and pharmaceutical companies discuss why marketers should take the plunge and how it could positively impact their businesses. Click here for more information and to register for this webcast. 

Sponsored by Google.

 



Advertise
For details on how to advertise in MM&M News Brief, please email Doreen Gates

Unsubscribe
To unsubscribe from the MM&M News Brief click here.
To manage your entire MM&M profile login to your account.

You are subscribed as: %%EMAIL%%

To contact Haymarket Media for general questions or unsubscribe problems, please reply to this email.

All MM&M newsletters are sent from the domain "email.mmm-online.com". When configuring e-mail or spam
filter rules, please use this domain name.

Medical Marketing & Media Magazine
114 W. 26th Street 4th Floor
New York N.Y. 10001
Phone: (646) 638-6000
Fax: (646) 638-6150
http://www.mmm-online.com/

© 2013 Haymarket Media Inc.